pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    relacorilant
    Lifyorli (relacorilant)
    Epithelial Ovarian Cancer$CORT CORCEPT THERAPEUTICS INC
  • Phase 2
    relatlimab
    relatlimab
    Metastatic Hepatocellular Carcinoma (HCC) Bristol-Myers Squibb Co
  • Phase 2
    remetinostat
    remetinostat
    Cutaneous T-Cell Lymphoma Biossil Inc
  • Phase 1
← prev
page 56 of 62
next →
Pain89
Neurology1
remzistotug
remzistotug
Breast Cancer
$GSK GSK plc
  • Phase 2
    rencofilstat
    rencofilstat
    Hepatocellular Carcinoma$HEPA Hepion Pharmaceuticals, Inc.
  • Marketed
    repotrectinib
    Augtyro (repotrectinib)
    Non-Small Cell Lung Cancer Bristol-Myers Squibb Co
  • Phase 2
    resiquimod
    resiquimod
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… SURGE Therapeutics Inc
  • Phase 2
    resiquimod sulfate
    resiquimod sulfate
    Squamous Non-Small Cell Lung Cancer$EIKN Eikon Therapeutics, Inc.
  • Phase 2
    rezatapopt
    rezatapopt
    Bile Duct Cancer (Cholangiocarcinoma)$PMVP PMV Pharmaceuticals, Inc.
  • Phase 2
    rhenium (186Re) obisbemeda
    Reyobiq (rhenium (186Re) obisbemeda)
    Malignant Glioma$PSTV PLUS THERAPEUTICS, INC.
  • Marketed
    ribociclib succinate
    Kisqali (ribociclib succinate)
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$NVS NOVARTIS AG
  • Phase 2
    rigosertib sodium
    rigosertib sodium
    Non-Small Cell Lung Cancer$TRAW Traws Pharma, Inc.
  • Phase 1
    rilogrotug
    rilogrotug
    Cancer Anorexia-Cachexia Syndrome AVEO Pharmaceuticals Inc
  • Phase 3
    rinatabart sesutecan
    rinatabart sesutecan
    Epithelial Ovarian Cancer Genmab AS
  • Phase 2
    rintatolimod
    Ampligen (rintatolimod)
    Epithelial Ovarian Cancer$AIM AIM ImmunoTech Inc.
  • Phase 1
    rinzimetostat
    rinzimetostat [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$ORIC Oric Pharmaceuticals, Inc.
  • Marketed
    ripretinib
    Qinlock (ripretinib)
    Gastrointestinal Stromal Tumor (GIST) Deciphera Pharmaceuticals Inc
  • Preclinical
    ritanserin
    ritanserin
    Glioblastoma Multiforme (GBM) University of Virginia
  • Marketed
    rituximab
    Rituxan (rituximab)
    B-Cell Leukemia Genentech Inc
  • pre_registration
    rituximab biosimilar
    Riabni (rituximab-arrx)
    Unspecified Cancer Dr. Reddy's Laboratories Ltd
  • Phase 2
    roginolisib
    roginolisib [INN]
    Metastatic Uveal Melanoma iOnctura SA
  • Phase 2
    rogocekib
    rogocekib [INN]
    Chronic Myelomonocytic Leukemia (CMML) Chordia Therapeutics Inc
  • Marketed
    romidepsin
    Romidepsin
    Cutaneous T-Cell Lymphoma Fresenius Kabi USA LLC
  • Phase 2
    rondecabtagene autoleucel
    rondecabtagene autoleucel [INN]
    Diffuse Large B-Cell Lymphoma$LYEL Lyell Immunopharma, Inc.
  • pre_registration
    ropeginterferon alfa-2b LA
    Besremi (ropeginterferon alfa-2b [INN])
    Essential Thrombocythemia PharmaEssentia Corp
  • Phase 2
    rose bengal sodium
    rose bengal sodium [INN]
    Metastatic Melanoma$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
  • Phase 2
    rosopatamab tetraxetan
    rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Convergent Therapeutics Inc
  • Phase 3
    rostaporfin
    rostaporfin
    Metastatic Breast Cancer TuHURA Biosciences Inc
  • Phase 2
    roxadustat
    roxadustat
    Myelodysplastic Syndrome (Preleukemia)$KYNB KYNTRA BIO, INC.
  • pre_registration
    rusfertide acetate
    rusfertide acetate
    Polycythemia Vera$PTGX Protagonist Therapeutics, Inc